Irene López Santiago

Hi! Could you please provide some follow-up on this issue? I would love to know if you have this work on the scope for the coming months. Please let me...

Hello! As @matentzn suggested in our conversation in August, we want to be able to accurately establish what are the levels of correspondence between terms so I've mapped our values...

Hi @matentzn! Yes, that is exactly the rationale the curation follows. 1. We haven't explored that. Correct me if I am wrong, but we don't have access to such synonyms...

Thank you @matentzn, I will be very happy to know your comments. 1. Sure, this is something that we can do. These MedDRA terms are picked up from our FAERS...

Thank you for the clarification. I don't think any checks of whether the Xref is already present were done.

Hi @matentzn @joeflack4, how is this work going? I'm interested to know if you have any initial thoughts on the quality of the data. Thanks!

Hi @matentzn. Thanks for the update. Could you tell me if the plan is still to review these manually? Please let me know when you start working in this so...

I'd like to follow up on this ticket as I am not sure of the necessity of a new term in this case anymore. The fact that the variant occurs...

Hi @egchr, as I mentioned above, this type of alteration is used in the Cancer Biomarkers Database. There are a number of bibliographic references as well (https://www.nature.com/articles/s41431-018-0097-3), so I think...

Hello, I have just noticed that the `disease susceptibility` branch ([MONDO_0042489](https://www.ebi.ac.uk/ols/ontologies/efo/terms?iri=http%3A%2F%2Fpurl.obolibrary.org%2Fobo%2FMONDO_0042489)) is not part of the EFO OTAR profile. At the same time, there are many susceptibility terms spread all...